Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Maintains Neutral Rating on Main Street Capital with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
OHI stock news
0
SHARES
22
VIEWS
Share on FacebookShare on Twitter

UBS analyst Vilas Abraham has kept a Neutral rating on Main Street Capital (NYSE: MAIN) while increasing the price target to $45 on March 2, 2024. This adjustment is in line with the overall positive momentum seen in the company. The new price target is consistent with the average target of $45.6 set by analysts, who have estimates ranging from $43 to $48.

Main Street Capital Corporation (MAIN) Shows Resilience with Slight Stock Drop – March 2, 2024 Performance Analysis

On March 2, 2024, Main Street Capital Corporation (MAIN) had a mixed performance in the stock market. The stock closed at $45.44, which was a decrease of $0.27 or 0.59% from the previous trading day. Despite this slight drop, MAIN is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating a strong price momentum for the stock.

After the market closed, MAIN saw a small uptick in after-hours trading, with the stock rising $0.03. This could indicate that investors are still bullish on MAIN and are willing to buy shares even after the regular trading hours have ended.

Main Street Capital Corporation is a publicly traded business development company that focuses on providing long-term debt and equity capital to lower middle market companies. The company has a strong track record of generating consistent returns for its investors, which has helped to support its stock price performance.

Overall, MAIN’s performance on March 2, 2024, suggests that the stock is still in a strong position despite the slight drop in price during regular trading hours. Investors may want to keep an eye on MAIN to see if the positive momentum continues in the days ahead.

MAIN Stock Shows Strong Performance with Growth in Revenue and Net Income

On March 2, 2024, MAIN stock showed strong performance with positive growth in both total revenue and net income compared to the previous year. According to data from CNN Money, MAIN reported total revenue of $401.93 million over the past year, which represents a 4.5% increase from the previous year. In the fourth quarter, the total revenue was $117.99 million, holding flat compared to the previous quarter.

The net income for MAIN was $428.45 million over the past year, showing an impressive 77.33% increase from the previous year. In the fourth quarter, the net income was $139.08 million, which also saw a significant increase of 34.69% from the previous quarter.

Earnings per share (EPS) for MAIN were reported at $5.23 over the past year, reflecting a 61.24% increase from the previous year. In the fourth quarter, the EPS was $1.65, holding flat compared to the previous quarter.

Overall, MAIN stock demonstrated strong financial performance with consistent growth in net income and EPS. Investors may view these positive results as a sign of the company’s financial stability and potential for future growth. It will be interesting to see how MAIN continues to perform in the coming quarters and whether it can sustain its positive momentum in the market.

Tags: MAIN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Analyst Reaffirms Neutral Rating on PayPal Holdings with Increased Price Target

Finance_Commercial (2)

Analysts Provide Mixed Ratings for NetApp Following Strong Q3 Earnings

Technology Quantum computing Market Capitalization

Analysts Offer Range of Perspectives on Autodesk Inc Following Strong Q4 Results

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com